|
TCF12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.803800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.843100E-04 |
| Normal-vs-Stage2 |
1.263010E-01 |
| Normal-vs-Stage3 |
1.341420E-01 |
| Normal-vs-Stage4 |
4.169200E-01 |
| Stage1-vs-Stage2 |
6.010600E-01 |
| Stage1-vs-Stage3 |
4.694200E-01 |
| Stage1-vs-Stage4 |
2.667600E-01 |
| Stage2-vs-Stage3 |
8.867000E-01 |
| Stage2-vs-Stage4 |
6.033200E-01 |
| Stage3-vs-Stage4 |
6.814200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015530E-02 |
| Normal-vs-AfricanAmerican |
2.40659999999338E-05 |
| Normal-vs-Asian |
6.218000E-01 |
| Caucasian-vs-AfricanAmerican |
6.517300E-03 |
| Caucasian-vs-Asian |
2.040600E-01 |
| AfricanAmerican-vs-Asian |
1.778160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.228500E-04 |
| Normal-vs-Female |
3.698800E-01 |
| Male-vs-Female |
2.107900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.544600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.252400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.881620E-02 |
| Normal-vs-Age(81-100Yrs) |
4.40769999998647E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.767000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.746200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.151600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.942400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.857300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.061200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.242200E-01 |
| Normal-vs-Grade 2 |
1.293510E-02 |
| Normal-vs-Grade 3 |
1.944670E-03 |
| Normal-vs-Grade 4 |
6.961800E-01 |
| Grade 1-vs-Grade 2 |
3.508000E-01 |
| Grade 1-vs-Grade 3 |
2.547600E-01 |
| Grade 1-vs-Grade 4 |
7.481600E-01 |
| Grade 2-vs-Grade 3 |
4.272000E-01 |
| Grade 2-vs-Grade 4 |
3.054000E-01 |
| Grade 3-vs-Grade 4 |
1.439810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.537700E-03 |
| Normal-vs-ccB subtype |
5.611000E-01 |
| ccA subtype-vs-ccB subtype |
7.181900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.607700E-02 |
| Normal-vs-N1 |
3.661400E-01 |
| N0-vs-N1 |
2.045600E-01 |
|
|
